👤 Duojia Pan

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧪 BiometalDB 🧬 Extraction
394
Articles
300
Name variants
Also published as: Ziqiang Pan, Shang-Ling Pan, Yinghong Pan, Yuwen Pan, Ying Pan, Shu-Ming Pan, Xiuyi Pan, Yong Pan, Yu-Jia Pan, Jian Pan, Yaoxin Pan, Tao Pan, David Z Pan, Jiandong Pan, Yuqin Pan, Qi Pan, Qiuwei Pan, Hongmei Pan, Yuchun Pan, Xuan Pan, Shuyi Pan, Xiangbin Pan, Zhen Pan, Wei Pan, Xuefang Pan, Wang Pan, Yunbing Pan, Xiaoqiong Pan, Hong Pan, Ting Pan, Jie Pan, Dongmei Pan, Yan Pan, Ying-Ni Pan, Huichao Pan, Yan-Jun Pan, Zengkai Pan, Wenzhi Pan, Yingtian Pan, Liangxuan Pan, Yuancheng Pan, Kai-Feng Pan, Yanpei Pan, Shilei Pan, De-Biao Pan, Zhang-Yi Pan, Edward Pan, Wen Pan, Chi-Jiunn Pan, Chengfu Pan, Hongming Pan, Ziwen Pan, Jianfeng Pan, Yijun Pan, Calvin Pan, Xiucheng Pan, Ziyi Pan, Yuesong Pan, Xiaoying Pan, Yifeng Pan, Heng Pan, Hanghai Pan, Hongbin Pan, Stephen Pan, Jincheng Pan, Cheol-Ho Pan, Deng Pan, Zixiang Pan, X Pan, Yanchao Pan, Chih-Chuan Pan, Cuili Pan, Jingye Pan, Min-Hsiung Pan, Zaixu Pan, Warren Pan, Kai Pan, Q R Pan, Junping Pan, Jirong Pan, Mingjie Pan, Ling-Ai Pan, Li-Hua Pan, Pauline Lining Pan, Hui Pan, Ching-Chian Pan, T Pan, Zimeng Pan, Xiaoyue Pan, Haobo Pan, Pan Pan, Menghao Pan, Kejian Pan, Gang Pan, Jia Pan, Zhe Pan, Jia-Xiang Pan, Ke Pan, Xinyun Pan, Yaping Pan, Xin Pan, Ye Pan, Yihan Pan, Yang Pan, Qiong Pan, Jian'an Pan, Xiaohong Pan, Jianxin Pan, Fan Pan, Linqing Pan, Zhisen Pan, Jiaxing Pan, Feng Pan, Yi Pan, Guo-zhong Pan, Shanshan Pan, Yifan Pan, Jun Pan, Wenwei Pan, Shien-Tung Pan, Bei Pan, Jialin Pan, Shifeng Pan, Lu Pan, Yangyang Pan, Yongchu Pan, Mengru Pan, Cuiping Pan, Hao Pan, Shou Pan, Jiaren Pan, Yihang Pan, Z M Pan, Xuebo Pan, Henan Pan, Liangbin Pan, Mengxia Pan, Xiaoxia Pan, Wilbur Pan, Yitao Pan, Bo Pan, Yuting Pan, Xiao-Xia Pan, Cuizhen Pan, Hongxu Pan, Mei Pan, Yongjie Pan, Jiongwei Pan, Shuya Pan, Chaomin Pan, Meng Pan, Yue Pan, Jinyu Pan, Zihong Pan, Yu Pan, Lina Pan, Xuehua Pan, Chuanying Pan, Xiao Pan, Liying Pan, Chunyu Pan, Bin Pan, Guangxin Pan, Hejing Pan, Wenjing Pan, Ping Pan, Lingling Pan, Ya-Xiong Pan, Juan Pan, Hung-Chuan Pan, Yihui Pan, Yuchun C Pan, Q Pan, Ming Pan, Alan P Pan, Meijun Pan, Yuan-Xiang Pan, Jiajie Pan, Xiaomin Pan, Qin Pan, Xinghua Pan, Zhi-Yuan Pan, Haitao Pan, Qiuling Pan, Y Pan, Zhenhua Pan, Dan Pan, Mei-Hung Pan, Chengliang Pan, Kylie S Pan, Mengxue Pan, Zhangyuan Pan, Xiao-Fu Pan, Defeng Pan, Xiaorong Pan, Hui-Ping Pan, Mengyu Pan, Wensheng Pan, Xue Pan, Y Z Pan, Tam In Pan, Xiong-Fei Pan, Allen L Pan, Siwei Pan, Lijuan Pan, Xingyan Pan, Qian Pan, Wen-Harn Pan, Yanchang Pan, Peijiang Pan, Mu-Su Pan, Yuan Pan, Tingting Pan, Zhi-Zhong Pan, Jun-Jie Pan, Yen-Ting Pan, Ying-Ru Pan, Xiaowen Pan, Xingxi Pan, Ziwei Pan, Yanfei Pan, Mingxia Pan, Zonghao Pan, Lei Pan, Jie-Li Pan, Meihui Pan, Xueliang Pan, Hongyuan Pan, Chin-Chen Pan, Zhuoyue Pan, Ting-Ting Pan, Bao-Long Pan, Peng Pan, Li Pan, Zhiyong Pan, Tingli Pan, Qiu-Ling Pan, Xinming Pan, Y X Pan, Yingzi Pan, Beibin Pan, De-Si Pan, Daodong Pan, Simiao Pan, Qiuhui Pan, Shengying Pan, Ruize Pan, Jing Pan, Yong-Quan Pan, Chenxi Pan, Qini Pan, Zihao Pan, Kaixin Pan, Xiaona Pan, Ziyue Pan, Haizhou Pan, Deyu Pan, Ya-Qiang Pan, Min Pan, Chien-Hsiung Pan, Peipei Pan, Junfan Pan, Xiuhua Pan, Haiyan Pan, Zhijun Pan, Bo-Yi Pan, Xingxiu Pan, Qianqian Pan, Kuo-Li Pan, Yueyin Pan, Yuancan Pan, Chunpeng Pan, Dejing Pan, Wenhao Pan, Chongge Pan, Sipei Pan, Meimei Pan, Yanan Pan, Yuchen Pan, Liming Pan, Mengshan Pan, Sheng Pan, Minghong Pan, Xiao-hua Pan, Manyi Pan, Hehai Pan, Hong-Wei Pan, Anni Pan, Huafeng Pan, Qiaoling Pan, Yanmeng Pan, Hai-Feng Pan, Haibang Pan, Dikang Pan, Liuliu Pan, Tai-Long Pan, Luqing Pan, Chen-Wen Pan, Ying-Hua Pan
articles
Guo-zhong Pan, Wen-ling Liu, Da-Yi Hu +5 more · 2006 · Zhonghua yi xue za zhi · added 2026-04-24
To compare the gene mutation between Chinese patients with familial and sporadic hypertrophic cardiomyopathy (HCM). Peripheral blood samples were collected from 36 patients with familial HCM (FHCM) an Show more
To compare the gene mutation between Chinese patients with familial and sporadic hypertrophic cardiomyopathy (HCM). Peripheral blood samples were collected from 36 patients with familial HCM (FHCM) and 50 patients with sporadic HCM (SHCM), all un-related and from different provinces of China. PCR was used to amplify the 26 protein-coding axons of beta-myosin heavy chain (MYH7), 16 exons for cardiac troponin T (TNNT2), and 38 exons for cardiac myosin-binding protein C (MYBPC3). The amplified products were sequenced and compared with the standard sequence in the genBank so as to determine the potential mutation sites. (1) 13 of the 36 FHCM patients (36.1%) harbored 3 different mutations in MYH7 gene: Arg663His in exon18, Glu924Lys in exon 23, and Ile736Thr in exon 20. Of the 50 SHCM patients, only 1 (2%) harbored MYH7 gene missence mutation: Ile736Thr located in exon 20. (2) TNNT2 was not identified in all SHCM patients and FHCM patients. (3) MYBPC3 was not identified in all SHCM patients. Four FHCM patients harbored 2 different mutations: Arg502Trp in exon 18 and Arg346fs in exon 13 respectively. MYH7 and MYBPC3 may be the dominant disease-causing genes in Chinese familial HCM patients; however the mutation rate of MYH7 and MYBPC3 genes is significantly lower in the SHCM patients compared with the FHCM patients. TNNT2 seems not the predominant disease-causing gene in all Chinese patients with HCM. Show less
no PDF
MYBPC3
Andrew D Nguyen, Chi-Jiunn Pan, Jeng-Jer Shieh +1 more · 2005 · FEBS letters · Elsevier · added 2026-04-24
Glycogen storage disease type Ia (GSD-Ia) patients manifest a pro-atherogenic lipid profile but are not at elevated risk for developing atherosclerosis. Serum phospholipid, which correlates positively Show more
Glycogen storage disease type Ia (GSD-Ia) patients manifest a pro-atherogenic lipid profile but are not at elevated risk for developing atherosclerosis. Serum phospholipid, which correlates positively with the scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux, and apolipoprotein A-IV and E, acceptors for ATP-binding cassette transporter A1 (ABCA1)-mediated cholesterol transport, are increased in GSD-Ia mice. Importantly, sera from GSD-Ia mice are more efficient than sera from control littermates in promoting SR-BI- and ABCA1-mediated cholesterol effluxes. As the first step in reverse cholesterol transport, essential for cholesterol homeostasis, these observations provide one explanation why GSD-Ia patients are apparently protected against premature atherosclerosis. Show less
no PDF DOI: 10.1016/j.febslet.2005.07.042
APOA4
J D Loeb, T A Kerentseva, T Pan +2 more · 1999 · Genetics · Oxford University Press · added 2026-04-24
Several lines of evidence suggest that the morphogenetic transition from the yeast form to pseudohyphae in Saccharomyces cerevisiae may be regulated by the cyclin-dependent kinase (Cdk). To examine th Show more
Several lines of evidence suggest that the morphogenetic transition from the yeast form to pseudohyphae in Saccharomyces cerevisiae may be regulated by the cyclin-dependent kinase (Cdk). To examine this hypothesis, we mutated all of the G1 cyclin genes in strains competent to form pseudohyphae. Interestingly, mutation of each G1 cyclin results in a different filamentation phenotype, varying from a significant defect in cln1/cln1 strains to enhancement of filament production in cln3/cln3 strains. cln1 cln2 double mutants are more defective in pseudohyphal development and haploid invasive growth than cln1 strains. FLO11 transcription, which correlates with the level of invasive growth, is low in cln1 cln2 mutants and high in grr1 cells (defective in proteolysis of Cln1,2), suggesting that Cln1,2/Cdks regulate the pseudohyphal transcriptional program. Epistasis analysis reveals that Cln1,2/Cdk and the filamentation MAP kinase pathway function in parallel in regulating filamentous and invasive growth. Cln1 and Cln2, but not Ste20 or Ste12, are responsible for most of the elevated FLO11 transcription in grr1 strains. Furthermore, phenotypic comparison of various filamentation mutants illustrates that cell elongation and invasion/cell-cell adhesion during filamentation are separable processes controlled by the pseudohyphal transcriptional program. Potential targets for G1 cyclin/Cdks during filamentous growth are discussed. Show less
no PDF DOI: 10.1093/genetics/153.4.1535
CLN3
L Xu, J Xia, H Jiang +7 more · 1999 · Human genetics · Springer · added 2026-04-24
Hereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant bone disorder. It is genetically heterogeneous with at least three chromosomal loci: EXT1 on 8q24.1, EXT2 on 11p11, and EXT3 on Show more
Hereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant bone disorder. It is genetically heterogeneous with at least three chromosomal loci: EXT1 on 8q24.1, EXT2 on 11p11, and EXT3 on 19p. EXT1 and EXT2, the two genes responsible for EXT1 and EXT2, respectively, have been cloned. Recently, three other members of the EXT gene family, named the EXT-like genes (EXTL: EXTL1, EXTL2, and EXTL3), have been isolated. EXT1, EXT2, and the three EXTLs are homologous with one another. We have identified the intron-exon boundaries of EXTL1 and EXTL3 and analyzed EXT1, EXT2, EXTL1, and EXTL3, in 36 Chinese families with EXT, to identify underlying disease-related mutations in the Chinese population. Of the 36 families, five and 12 family groups have mutations in EXT1 and EXT2, respectively. No disease-related mutation has been found in either EXTL1 or EXTL2, although one polymorphism has been detected in EXTL1. Of the 15 different mutations (three families share a common mutation in EXT2), 12 are novel. Most of the mutations are either frameshift or nonsense mutations (12/15). These mutations lead directly or indirectly to premature stop codons, and the mutations generate truncated proteins. This finding is consistent with the hypothesis that the development of EXT is mainly attributable to loss of gene function. Missense mutations are rare in our families, but these mutations may reflect some functionally crucial regions of these proteins. EXT1 is the most frequent single cause of EXT in the Caucasian population in Europe and North America. It accounts for about 40% of cases of EXT. Our study of 36 EXT Chinese families has found that EXT1 seems much less common in the Chinese population, although the frequency of the EXT2 mutation is similar in the Caucasian and Chinese populations. Our findings suggest a possibly different genetic spectrum of this disease in different populations. Show less
no PDF DOI: 10.1007/s004399900058
EXT1